- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Osteoporosis
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 611KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 122KB)
Romosozumab – March 2024
Romosozumab: Injection 105 mg in 1.17 mL single use pre filled syringe; Evenity®
Last updated
30 May 2025